Gasimli K, et al. - Among patients with different histological tumor-free margin (hTFM) and in primary vulvar cancer, researchers examined the role of residual VIN III re-excision and compared differences in disease-free survival via retrospectively analyzing 42 patients with residual adjacent VIN III following primary surgery for vulvar cancer who were operated on between 2000 and 2016 in their clinic. In vulvar cancer patients, findings suggest a potential utility of hTFM as a predictive indicator for disease-free survival. They could not show re-excision for residual adjacent VIN III as a predictive factor for DFS after primary surgery in squamous cell cancer of vulva.